Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
- González-Martín, A.
- Rubio, M.J.
- Heitz, F.
- Depont Christensen, R.
- Colombo, N.
- Van Gorp, T.
- Romeo, M.
- Ray-Coquard, I.
- Gaba, L.
- Leary, A.
- De Sande, L.M.
- Lebreton, C.
- Redondo, A.
- Fabbro, M.
- Barretina Ginesta, M.-P.
- Follana, P.
- Pérez-Fidalgo, J.A.
- Rodrigues, M.
- Santaballa, A.
- Sabatier, R.
- Bermejo-Pérez, M.J.
- Lotz, J.-P.
- Pardo, B.
- Marquina, G.
- Sánchez-Lorenzo, L.
- Quindós, M.
- Estévez-García, P.
- Guerra Alía, E.
- Manso, L.
- Casado, V.
- Kommoss, S.
- Tognon, G.
- Henry, S.
- Bruchim, I.
- Oaknin, A.
- Selle, F.
- Show all authors +
Journal:
Journal of Clinical Oncology
ISSN: 1527-7755, 0732-183X
Year of publication: 2024
Type: Article